To our knowledge, this is the first study to identify MYC target genes in relevant B cells that directly convert to lymphoma cells in response to increasing wild type or mutant (T58A and T58I) MYC levels, due to the prior disruption of apoptosis- and cellular senescence-inducing pathways. This evidence concerns the gene MYC and lymphoma.